盈康生命科技股份有限公司

Core Viewpoint - The company, Yingkang Life, has made significant strategic moves, including the acquisition of a 51% stake in Changsha Kexin Tumor Hospital to enhance its capabilities in the medical services sector and improve its financial performance [8]. Group 1: Financial and Operational Highlights - The company plans not to distribute cash dividends or issue bonus shares for the reporting period [2]. - A change in accounting policy was implemented, affecting the recognition of estimated liabilities related to quality guarantees, which will be reflected in the financial statements [3]. - The total amount for the acquisition of the 51% stake in Changsha Kexin is RMB 357 million, funded through self-owned and self-raised funds [8]. Group 2: Corporate Governance Changes - The company experienced changes in its board of directors, with the resignation of the general manager and a vice president, leading to the appointment of a new general manager [10]. - The board approved the nomination of new non-independent directors to ensure compliance with corporate governance standards [10]. Group 3: Structural Adjustments - The company is restructuring its subsidiaries into two major platforms: medical devices and medical services, to enhance resource integration capabilities [10].